Similarly, analogous results were observed for the expression pattern of BAL2 in BC patients with corresponding clinical characteristics, except that no significant differences were observed in the expression levels of BAL2 among the distinct subtypes (Fig. 4). This evidence concerns the gene PARP14 and breast cancer.